Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

6.1K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

8.0K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FRZB-induced anti-angiogenic effect via Caveolin-1-mediated TGFβ signalling.

Nature communications·2026
Same author

Epitranscriptomic Dysregulation Underpins Artemisinin Mechanism of Action.

bioRxiv : the preprint server for biology·2025
Same author

Driving cognitive change: a guide to behavioural experiments in cognitive therapy for anxiety disorders and PTSD.

Cognitive behaviour therapy·2025
Same author

Iron deficiency causes aspartate-sensitive dysfunction in CD8<sup>+</sup> T cells.

Nature communications·2025
Same author

Characterizing Surface Deformation of the Earthquake-Induced Daguangbao Landslide by Combining Satellite- and Ground-Based InSAR.

Sensors (Basel, Switzerland)·2025
Same author

Impact of interaction between individual genomes and preeclampsia on the severity of autism spectrum disorder symptoms.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences·2025

Related Experiment Video

Updated: Oct 20, 2025

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye
11:49

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye

Published on: August 16, 2014

17.0K

Complement Factor B Mediates Ocular Angiogenesis through Regulating the VEGF Signaling Pathway.

Hannah Murray1, Beiying Qiu2,3, Sze Yuan Ho2,3,4

  • 1Institute of Molecular and Cell Biology, Agency for Science Technology and Research (A*STAR), Proteos, 61 Biopolis Dr., Singapore 138673, Singapore.

International Journal of Molecular Sciences
|September 10, 2021
PubMed
Summary

Complement factor B (CFB) promotes pathological ocular neovascularization by mediating vascular endothelial growth factor (VEGF) signaling. This study clarifies CFB

Keywords:
VEGFangiogenesiscomplement factor Beye

More Related Videos

An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis
06:10

An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis

Published on: August 6, 2020

5.9K
In Vitro Model of Coronary Angiogenesis
08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

8.0K

Related Experiment Videos

Last Updated: Oct 20, 2025

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye
11:49

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye

Published on: August 16, 2014

17.0K
An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis
06:10

An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis

Published on: August 6, 2020

5.9K
In Vitro Model of Coronary Angiogenesis
08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

8.0K

Area of Science:

  • Immunology
  • Ophthalmology
  • Angiogenesis Research

Background:

  • Complement factor B (CFB) is a key component of the complement alternative pathway (AP).
  • CFB's role in pathological ocular neovascularization is debated, necessitating further investigation.
  • Ocular neovascularization contributes to several blinding eye diseases.

Purpose of the Study:

  • To investigate the direct impact of Complement factor B (CFB) on ocular neovascularization.
  • To elucidate the mechanisms underlying CFB's role in pathological angiogenesis.

Main Methods:

  • Utilized mouse models of laser-induced choroidal neovascularization (CNV) and oxygen-induced retinopathy (OIR).
  • Conducted in vitro and ex vivo functionality assays.
  • Analyzed Complement factor B (CFB) expression and its effect on VEGF signaling.

Main Results:

  • Demonstrated increased CFB expression during pathological angiogenesis in mouse models.
  • Showcased a promoting effect of CFB on angiogenesis through in vitro and ex vivo assays.
  • Identified CFB's pro-angiogenic mechanism via mediation of the vascular endothelial growth factor (VEGF) signaling pathway.

Conclusions:

  • Complement factor B (CFB) plays a significant role in driving ocular angiogenesis.
  • CFB exerts its pro-angiogenic effects in a VEGF-dependent manner.
  • Findings provide a basis for future research into CFB-mediated ocular angiogenesis.